About Gerald Brunk
Gerald Brunk is a director of Endogenex. Endogenex’s investigational system is for people with type 2 diabetes. He co-founded Lumira Ventures and is a managing director at the healthcare venture capital firm. He has led biotechnology and medical device investments in MAKO Surgical, Pharmasset, HistoSonics, Endotronix, Cadence Neuroscience and Bardy Diagnostics. He has served on enGene Holdings’ board since 2023 and chairs its compensation committee.
Before venture investing, he co-founded several venture-backed healthcare companies. He was an engagement manager in The Boston Consulting Group’s healthcare practice from 1994 to 1999. He previously worked in Credit Suisse First Boston’s investment banking group from 1990 to 1992. He earned an MBA from Stanford and a bachelor’s degree from the University of Virginia.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Gerald Brunk in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Gerald Brunk works with at each company, as listed on that company's latest Form D.
